Phase I and pharmacokinetic study of docetaxel, irinotecan, and celecoxib in patients with advanced non-small cell lung cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Oncology
Link
http://link.springer.com/content/pdf/10.1007/s10637-005-3259-4.pdf
Reference50 articles.
1. Argiris A, Schiller JH: Can current treatments for advanced non-small-cell lung cancer be improved? JAMA 292: 499–500, 2004.
2. Smit EF, van Meerbeeck JP, Lianes P, et al.: Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: A phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group—EORTC 08975. J Clin Oncol 21: 3909–3917, 2003.
3. Schiller JH: Platin or no platin? That is the question. J Clin Oncol 21: 3009–3010, 2003.
4. Ramalingam S, Belani CP: Basic treatment considerations: Chemotherapy. Hematol Oncol Clin North Am 18: 13–28, 2004.
5. Argiris A, Murren JR: Cinical use of the camptothecins at year 2000. PPO updates 14: 1–15 2000.
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Discovery, synthesis, and anti-cancer evaluation of 10-Pterostilbene methylamine hydrochloride derivatives as potential COX-2 and Topo I dual inhibitors;Journal of Molecular Structure;2024-09
2. Small-molecule drugs of colorectal cancer: Current status and future directions;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-01
3. Discovery of dual inhibitors of topoisomerase I and Cyclooxygenase-2 for colon cancer therapy;European Journal of Medicinal Chemistry;2022-10
4. Tumor microenvironment remodeling-based penetration strategies to amplify nanodrug accessibility to tumor parenchyma;Advanced Drug Delivery Reviews;2021-05
5. Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics;Clinical Pharmacokinetics;2018-03-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3